Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
3.520
+0.170 (5.07%)
At close: May 22, 2026, 4:00 PM EDT
3.459
-0.061 (-1.73%)
After-hours: May 22, 2026, 7:44 PM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $199.43 million as of May 22, 2026. Its market cap has increased by 5,956.61% in one year.
Market Cap
199.43M
Enterprise Value
157.90M
1-Year Change
5,956.61%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $199.43M, an increase of 512.46%. That is a compound annual growth rate of 51.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 199.43M | 80.60% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 202.41M |
| Milestone Pharmaceuticals | 199.31M |
| Cartesian Therapeutics | 198.91M |
| Innate Pharma | 195.68M |
| AN2 Therapeutics | 187.36M |
| Precision BioSciences | 185.26M |
| Karyopharm Therapeutics | 185.15M |
| Acumen Pharmaceuticals | 184.54M |